1: Capponi R, Hormazabal L, Schmid-Burgk W. Diclofensine and imipramine. A double-blind comparative trial in depressive out-patients. Neuropsychobiology. 1985;14(4):173-80. doi: 10.1159/000118224. PMID: 3915058.
2: Gasić S, Korn A, Eichler HG. Effect of diclofensine, a novel antidepressant, on peripheral adrenergic function. Clin Pharmacol Ther. 1986 May;39(5):582-5. doi: 10.1038/clpt.1986.100. PMID: 3698467.
3: Luethi D, Hoener MC, Liechti ME. Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems. Eur J Pharmacol. 2018 Jan 15;819:242-247. doi: 10.1016/j.ejphar.2017.12.012. Epub 2017 Dec 7. PMID: 29225192.
4: Cherpillod C, Omer LM. A controlled trial with diclofensine, a new psychoactive drug, in the treatment of depression. J Int Med Res. 1981;9(5):324-9. doi: 10.1177/030006058100900505. PMID: 7028532.
5: Jansen W, Brückner GW, Henauer S, Omer LM. Klinischer Doppelblindvergleich von Diclofensin und Plazebo bei geriatrischen Patienten mit depressiven Verstimmungszuständen [Clinical double blind comparison of diclofensine and placebo in geriatric patients with depressive syndromes]. Pharmacopsychiatria. 1982 Nov;15(6):205-9. German. doi: 10.1055/s-2007-1019539. PMID: 6760217.
6: Keller HH, Schaffner R, Carruba MO, Burkard WP, Pieri M, Bonetti EP, Scherschlicht R, Da Prada M, Haefely WE. Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine. Adv Biochem Psychopharmacol. 1982;31:249-63. PMID: 6979165.
7: Di Renzo G, Amoroso S, Taglialatela M, Canzoniero LM, Maida P, Lombardi G, Annunziato L. Pure uptake blockers of dopamine can reduce prolactin secretion: studies with diclofensine. Life Sci. 1988;42(21):2161-9. doi: 10.1016/0024-3205(88)90131-2. PMID: 2968488.
8: Culig J, Ehsanullah RS, Hallett C, Iliopoulou A, Matheson I, Turner P. A clinical pharmacological comparison of diclofensine (Ro 8-4650) with nomifensine and amitriptyline in normal human volunteers. Br J Clin Pharmacol. 1983 May;15(5):537-43. doi: 10.1111/j.1365-2125.1983.tb02087.x. PMID: 6860528; PMCID: PMC1427714.
9: Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology (Berl). 1990;102(2):183-90. doi: 10.1007/BF02245920. PMID: 2125734.
10: Omer OL, Díaz-Olivera M, Ismail S. Therapeutic efficacy and tolerance of diclofensine in psychoreactive depression--a double-blind comparison with placebo. Methods Find Exp Clin Pharmacol. 1984 Mar;6(3):147-51. PMID: 6379345.
11: Omer LM. Pilot trials with diclofensine, a new psychoactive drug in depressed patients. Int J Clin Pharmacol Ther Toxicol. 1982 Jul;20(7):320-6. PMID: 7107085.
12: Jackson SH, Turner P, Ehsanullah RS. A comparison of diclofensine and desmethylimipramine using tyramine pressor tests in normal subjects. Br J Clin Pharmacol. 1983 Oct;16(4):427-9. doi: 10.1111/j.1365-2125.1983.tb02189.x. PMID: 6626436; PMCID: PMC1428037.
13: Funke HJ, Holtmann W, Ismail S, Jansen W, Leonhardt KF, Muth H, Omer LM, O'Connolly M, Ramm H. Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood. Pharmacopsychiatry. 1986 May;19(3):120-3. doi: 10.1055/s-2007-1017168. PMID: 3725890.
14: Strojny N, de Silva JA. Determination of diclofensine, an antidepressant agent, and its major metabolites in human plasma by high-performance liquid chromatography with fluorometric detection. J Chromatogr. 1985 Jun 14;341(2):313-31. doi: 10.1016/s0378-4347(00)84045-1. PMID: 4030982.
15: Manna SK, Panda G. Synthesis of enantiomerically enriched indolines and tetrahydroisoquinolines from (S)-amino acid-derived chiral carbocations: an easy access to (3S,4R)-demethoxy-3-isopropyl diclofensine. Org Biomol Chem. 2014 Nov 7;12(41):8318-24. doi: 10.1039/c4ob00922c. Epub 2014 Sep 11. PMID: 25208820.
16: Hojabri H, Dadgar D, Glennon JD. Gas-liquid chromatographic analysis with electron-capture detection of diclofensine in human plasma following derivatization. J Chromatogr. 1984 Nov 9;311(1):189-93. doi: 10.1016/s0378-4347(00)84708-8. PMID: 6520163.
17: Meyer MR, Wagmann L, Schneider-Daum N, Loretz B, de Souza Carvalho C, Lehr CM, Maurer HH. P-glycoprotein interactions of novel psychoactive substances - stimulation of ATP consumption and transport across Caco-2 monolayers. Biochem Pharmacol. 2015 Apr 1;94(3):220-6. doi: 10.1016/j.bcp.2015.01.008. Epub 2015 Jan 28. PMID: 25637762.
18: Tian D, Li C, Gu G, Peng H, Zhang X, Tang W. Stereospecific Nucleophilic Substitution with Arylboronic Acids as Nucleophiles in the Presence of a CONH Group. Angew Chem Int Ed Engl. 2018 Jun 11;57(24):7176-7180. doi: 10.1002/anie.201712829. Epub 2018 May 9. PMID: 29687594.
19: Nakachi N, Kiuchi Y, Inagaki M, Inazu M, Yamazaki Y, Oguchi K. Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats. Eur J Pharmacol. 1995 Aug 4;281(2):195-203. doi: 10.1016/0014-2999(95)00246-h. PMID: 7589207.
20: Hyttel J, Larsen JJ. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin. J Neurochem. 1985 May;44(5):1615-22. doi: 10.1111/j.1471-4159.1985.tb08803.x. PMID: 2580950.